Posts by admin
Genome editing to produce monosex and sterile fish for aquaculture
Using genome editing to mass-produce reproductively sterile fish for aquaculture will increase culture performance and environmental sustainability.
Read MoreLatest developments in sustainable aquaculture feeds
Many feed ingredients have been developed for aquaculture species with the primary goal of reducing reliance on fishmeal and fish oil. There is an urgent need to consider sustainability goals beyond fishmeal and fish oil replacement to support the future growth of aquaculture. In this presentation, Dr. Andre Dumas addresses novel ingredients to meet the nutrient requirements of aquatic species and suggests strategies to develop sustainable feeds.
Read MoreEmerging diseases of global Atlantic salmon Aquaculture
Emerging diseases in aquatic species are increasing in incidence and are typically difficult to control due to the limited availability of preventative or therapeutic treatments. CAT’s Director of Fish Health, Dr. Mark Braceland, presents on emerging pathogens and diseases in Atlantic salmon (Salmo salar L.) in Scotland, Norway, Canada, and Chile with reflections on mitigation and management strategies, as well as the development of in vitro and in vivo disease challenge models at CAT which are positioned to aid in the development of technologies and management practices to reduce their impacts.
Read MoreTools for genetic improvement in aquaculture
Recent years have validated the benefit of genetic improvement of fish stocks in increasing aquaculture productivity – the application of genetic and genomic tools to breeding continues to revolutionize the industry. In this presentation, our CEO, Dr. John Buchanan, explores the types of tools available to companies in the sector and discusses how their application can promote genetic improvement in aquatic species.
Read MoreHow to improve your genetics
The aquaculture industry is ripe for the uptake of DNA-based technologies also known as genomics. The sector has observed and, therefore, learned lessons from the livestock industry where DNA tools are heavily applied, and genetic gains are no longer simulations on a computer screen. Many aquaculture producers have questions and are seeking guidance to improve…
Read MoreCAT to Open Aqua FeedTech Center in 2021
Souris, PE (October 29, 2020) – The Center for Aquaculture Technologies (CAT) is once again proving its versatility as a major player in the global Aquaculture Industry with plans for a new Aqua FeedTech extrusion facility. The CAT AQUA FeedTech Center will be the first of its kind in Canada, that is available to third…
Read MoreCAT Opens Third Facility
Victoria, PE (October 15, 2020) – The newest location for the Center for Aquaculture Technologies (CAT) is officially open for business. The state-of-the-art facility, located in Victoria, PE, was acquired by CAT in early 2020 and became the third location for the company, tripling its Canadian footprint and expanding the already best-in-class research services in…
Read MoreLaunch of AQUAarray HD
The Center for Aquaculture Technologies Launches Innovative Genotyping Tool AQUAarray HD [vannamei] The Center for Aquaculture Technologies (CAT), a leader in the field of genetic improvement of aquatic species, has launched the AQUAarray HD [vannamei], a universally applicable tool incorporating the latest advancements in genetic marker information for whiteleg shrimp. ”CAT is proud to offer…
Read MoreDEAL TO ACQUIRE NEW FACILITY
Souris, PE (February 21, 2020) – The Center for Aquaculture Technologies (CAT) has finalized a deal with Elanco Animal Health Incorporated to acquire a 46,000 square foot aquatic animal research facility in Victoria, Prince Edward Island. The acquisition, which includes expansive, purpose-built, wet and dry lab space, is an exciting step as CAT grows its…
Read MoreSALE TO CUNA DEL MAR
On April 23, 2019, all shares in leading aquaculture R&D company The Center for Aquaculture Technologies (CAT), were purchased by Cuna Del Mar LP (CDM), a US-based aquaculture investment fund, for an undisclosed amount from Linnaeus Capital Partners BV. Dr. John Buchanan, CEO of CAT, commented: “We look forward to working within Cuna del Mar,…
Read More